Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)
Sponsor: Children's Oncology Group
A PHASE3 clinical study on Acute Lymphoblastic Leukemia and Childhood B Acute Lymphoblastic Leukemia, this trial is completed. The trial is conducted by Children's Oncology Group and has accumulated 12 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Sep 2021 — Jul 2024 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Apr 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE3
Status: Unknown Status → Active Not Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Unknown Status PHASE3
-
Aug 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Apr 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE3
Status: Completed → Active Not Recruiting
-
Aug 2018 — Apr 2020 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Jun 2018 — Aug 2018 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Apr 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Oncology Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .